SCHEMBL7142113

SCHEMBL7142113

N[C@H]([C]=O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 11/20 0.67
THRA P10827 8/20 0.67
MEN1 O00255 7/20 0.67
KMT2A Q03164 7/20 0.67
PPARG P37231 6/20 0.67
LMNA P02545 5/20 0.67
USP2 O75604 4/20 0.67
HSD17B10 Q99714 3/20 0.67
TTR P02766 2/20 0.67
ADORA3 P0DMS8 2/20 0.67
PDE4D Q08499 2/20 0.67
RXRA P19793 2/20 0.67
ALDH1A1 P00352 2/20 0.67
MAPT P10636 2/20 0.67
NR1I2 O75469 2/20 0.67
NR3C1 P04150 1/20 0.67
CYP1A2 P05177 1/20 0.67
HTR1A P08908 1/20 0.67
CYP2C9 P11712 1/20 0.67
TBXA2R P21731 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7139433 1.00 THRB (0.67) THRBTHRAMEN1KMT2APPARG
SCHEMBL7142110 1.00 THRB (0.67) THRBTHRAMEN1KMT2APPARG
SCHEMBL6041028 0.87 SIRT5 (0.50) THRBTHRAMEN1KMT2APPARG
SCHEMBL6041026 0.87 SIRT5 (0.50) THRBTHRAMEN1KMT2APPARG
SCHEMBL13662871 0.82 THRB (0.70) THRBTHRAMEN1KMT2APPARG
SCHEMBL20016234 0.82 THRB (0.70) THRBTHRAMEN1KMT2APPARG
Levothyroxine SCHEMBL1997042 0.82 THRB (0.97) THRBTHRAMEN1KMT2APPARG
Thyroxine SCHEMBL2014581 0.82 THRB (0.97) THRBTHRAMEN1KMT2APPARG
Levothyroxine SCHEMBL1995241 0.82 THRB (0.97) THRBTHRAMEN1KMT2APPARG
Dextrothyroxine SCHEMBL1477972 0.82 THRB (0.97) THRBTHRAMEN1KMT2APPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030186847-A1 Insulin derivatives and synthesis thereof BTG INTERNATIONAL LIMITED (GB) 2003-10-02 US disclosed
EP-1299418-A1 INSULIN DERIVATIVES AND SYNTHESIS THEREOF BTG INTERNATIONAL LIMITED (Company No. 2664412) (GB) 2003-04-09 EP disclosed
WO-2002004515-A1 INSULIN DERIVATIVES AND SYNTHESIS THEREOF BTG INTERNATIONAL LIMITED (GB) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030186847-A1 Insulin derivatives and synthesis thereof THRB, IRS1, IGFBP1 THRB 1/4885THRA 10/4885MEN1 553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.